A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells

References

• Cheng YJ, Zhang AQ, Hu JJ, He F, Zeng X, Zhang XZ. Multifunctional peptide-amphiphile end-capped mesoporous silica nanoparticles for tumor targeting drug delivery. ACS Appl Mater Interfaces. 2017;9(3):2093–2103. doi:10.1021/acsami.6b1264728032742
   PubMed Web of Science ®Google Scholar
• Yi S, Zheng J, Lv P, et al. Controlled drug release from cyclodextrin-gated mesoporous silica nanoparticles based on switchable host-guest interactions. Bioconjug Chem. 2018;29(9):2884–2891.30074757
   PubMed Web of Science ®Google Scholar
• Lu ZR, Qiao P. Drug delivery in cancer therapy, quo vadis? Mol Pharm. 2018;15(9):3603–3616.29553749
   PubMedGoogle Scholar
• Palanikumar L, Kim J, Oh JY, et al. Hyaluronic acid-modified polymeric gatekeepers on biodegradable mesoporous silica nanoparticles for targeted cancer therapy. Acs Biomater Sci Eng. 2018;4(5):1716–1722.
   PubMed Web of Science ®Google Scholar
• Llopis-Lorente A, de Luis B, García-Fernández A, et al. Hybrid mesoporous nanocarriers act by processing logic tasks: toward the design of nanobots capable of reading information from the environment. ACS Appl Mater Interfaces. 2018;10(31):26494–26500.30016064
   PubMed Web of Science ®Google Scholar
• Hao WJ, Shen YX, Liu DY, et al. Dual-pH-sensitivity and tumour targeting core-shell particles for intracellular drug delivery. RSC Adv. 2017;7(2):851–860.
   Web of Science ®Google Scholar
• Aznar E, Oroval M, Pascual L, Murguía JR, Martínez-Máñez R, Sancenón F. Gated materials for on-command release of guest molecules. Chem Rev. 2016;116(2):561–718.26730615
   PubMed Web of Science ®Google Scholar
• Knežević NŽ, Lin VS. A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug. Nanoscale. 2013;5(4):1544–1551.23322330
   PubMed Web of Science ®Google Scholar
• Li Y, Duo YH, Bao SY, et al. EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer. Int J Nanomedicine. 2017;12:6239–6257.28894364
   PubMed Web of Science ®Google Scholar
• Louguet S, Rousseau B, Epherre R, et al. Thermoresponsive polymer brush-functionalized magnetic manganite nanoparticles for remotely triggered drug release. Polym Chem. 2012;3(6):1408–1417. doi:10.1039/c2py20089a
   Web of Science ®Google Scholar
• Meng H, Wang MY, Liu HY, et al. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice (vol 9, pg 3540, 2015). ACS Nano. 2016;10(6):6416. doi:10.1021/acsnano.6b0311027199284
   PubMedGoogle Scholar
• Chen X, Sun H, Hu J, Han X, Liu H, Hu Y. Transferrin gated mesoporous silica nanoparticles for redox-responsive and targeted drug delivery. Colloids Surf B Biointerfaces. 2017;152:77. doi:10.1016/j.colsurfb.2017.01.01028088015
   PubMed Web of Science ®Google Scholar
• Choi YL, Ji HL, Jaworski J, Jung JH. Mesoporous silica nanoparticles functionalized with a thymidine derivative for controlled release. J Mater Chem. 2012;22(19):9455–9457. doi:10.1039/c2jm30995e
   Web of Science ®Google Scholar
• Aznar E, Villalonga R, Giménez C, et al. Glucose-triggered release using enzyme-gated mesoporous silica nanoparticles. Chem commun. 2013;49(57):6391. doi:10.1039/c3cc42210k
   PubMed Web of Science ®Google Scholar
• Yan H, Teh C, Sreejith S, et al. Functional mesoporous silica nanoparticles for photothermal-controlled drug delivery in vivo. Angewandte Chemie Inter Ed. 2012;51(33):8373–8377. doi:10.1002/anie.201203993
   PubMed Web of Science ®Google Scholar
• Hu C, West KR, Scherman OA. Hollow mesoporous raspberry-like colloids with removable caps as photoresponsive nanocontainers. Nanoscale. 2016;8(15):7840–7844. doi:10.1039/c6nr01016d27010833
   PubMedGoogle Scholar
• Schmidt B, Barner-Kowollik C. Dynamic macromolecular material design-the versatility of cyclodextrin-based host-guest chemistry. Angewandte Chemie-Inter Ed. 2017;56(29):8350–8369. doi:10.1002/anie.201612150
   PubMed Web of Science ®Google Scholar
• Qu HN, Yang LR, Yu JM, et al. A redox responsive controlled release system using mesoporous silica nanoparticles capped with Au nanoparticles. RSC Adv. 2017;7(57):35704–35710. doi:10.1039/C7RA04444E
   Web of Science ®Google Scholar
• Llopis-Lorente A, Diez P, de la Torre C, et al. Enzyme-controlled nanodevice for acetylcholine-triggered cargo delivery based on Janus Au-mesoporous silica nanoparticles. Chem a Eur J. 2017;23(18):4276–4281. doi:10.1002/chem.201700603
   PubMed Web of Science ®Google Scholar
• Pourjavadi A, Tehrani ZM. Poly(N-isopropylacrylamide)-coated -cyclodextrin-capped magnetic mesoporous silica nanoparticles exhibiting thermal and pH dual response for triggered anticancer drug delivery. Int J Polym Mater Polym Biomater. 2017;66(7):336–348. doi:10.1080/00914037.2016.1217531
   Web of Science ®Google Scholar
• Wang DS, Wu S. Red-light-responsive supramolecular valves for photocontrolled drug release from mesoporous nanoparticles. Langmuir. 2016;32(2):632–636. doi:10.1021/acs.langmuir.5b0439926700509
   PubMed Web of Science ®Google Scholar
• Yu JM, Qu HN, Dong TT, Rong M, Yang LR, Liu HZ. A reversible light-responsive assembly system based on host-guest interaction for controlled release. New J Chem. 2018;42(8):6532–6537. doi:10.1039/C8NJ00014J
   Web of Science ®Google Scholar
• Ma HM, Wang YG, Wu D, et al. A novel controlled release immunosensor based on benzimidazole functionalized SiO2 and cyclodextrin functionalized gold Scientific Reports. 2016;6:19797.26791418
   PubMedGoogle Scholar
• Li Q-L, Wang D, Cui Y, et al. AIEgen-functionalized mesoporous silica gated by cyclodextrin-modified CuS for cell imaging and chemo-photothermal cancer therapy. ACS Appl Mater Interfaces. 2018;10(15):12155–12163. doi:10.1021/acsami.7b1456629261277
   PubMed Web of Science ®Google Scholar
• Meng HA, Xue M, Xia TA, et al. Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves. J Am Chem Soc. 2010;132(36):12690–12697. doi:10.1021/ja104501a20718462
   PubMed Web of Science ®Google Scholar
• Zhang Z, Ding J, Chen X, et al. Intracellular pH-sensitive supramolecular amphiphiles based on host–guest recognition between benzimidazole and β-cyclodextrin as potential drug delivery vehicles. Polym Chem. 2013;4(11):3265. doi:10.1039/c3py00141e
   Web of Science ®Google Scholar
• Li Z, Clemens DL, Lee B-Y, Dillon BJ, Horwitz MA, Zink JI. Mesoporous silica nanoparticles with pH-sensitive nanovalves for delivery of moxifloxacin provide improved treatment of lethal pneumonic tularemia. ACS Nano. 2015;9(11):10778–10789. doi:10.1021/acsnano.5b0430626435204
   PubMedGoogle Scholar
• Zhang Y, Chang YQ, Han L, et al. Aptamer-anchored di-polymer shell-capped mesoporous carbon as a drug carrier for bi-trigger targeted drug delivery. J Mater Chem B. 2017;5(33):6882–6889. doi:10.1039/C7TB01528C
   PubMed Web of Science ®Google Scholar
• Chen ZH, Sun M, Luo F, Xu KF, Lin ZY, Zhang L. Stimulus-response click chemistry based aptamer-functionalized mesoporous silica nanoparticles for fluorescence detection of thrombin. Talanta. 2018;178:563–568. doi:10.1016/j.talanta.2017.09.04329136862
   PubMedGoogle Scholar
• Jia X, Wang W, Han Q, Wang Z, Jia Y, Hu Z. Micromixer based preparation of functionalized liposomes and targeting drug delivery. ACS Med Chem Lett. 2016;7(4):429–434.27096054
   PubMed Web of Science ®Google Scholar
• Zhang J, Yuan ZF, Wang Y, et al. Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery. J Am Chem Soc. 2013;135(13):5068–5073.23464924
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang S, Zhang D, Bai X, Hecht SM, Chen S. DNA-affibody nanoparticles for inhibiting breast cancer cells overexpressing HER2. Chem commun. 2017;53(3):573–576.
   PubMed Web of Science ®Google Scholar
• Shao FY, Zhang LH, Jiao L, et al. Enzyme-free immunosorbent assay of prostate specific antigen amplified by releasing pH indicator molecules entrapped in mesoporous silica nanoparticles. Anal Chem. 2018;90(14):8673–8679.29916251
   PubMed Web of Science ®Google Scholar
• Jiang F, Liu BA, Lu J, et al. Progress and challenges in developing aptamer-functionalized targeted drug delivery systems. Int J Mol Sci. 2015;16(10):23784–23822.26473828
   PubMed Web of Science ®Google Scholar
• Lassalle HP, Marchal S, Guillemin F, Reinhard A, Bezdetnaya L. Aptamers as remarkable diagnostic and therapeutic agents in cancer treatment. Curr Drug Metab. 2012;13(8):1130–1144.22380008
   PubMed Web of Science ®Google Scholar
• Zhou ZZ, Liu MY, Jiang JH. The potential of aptamers for cancer research. Anal Biochem. 2018;549:91–95.29548926
   PubMed Web of Science ®Google Scholar
• Zhu J, Huang H, Dong SW, Ge L, Zhang Y. Progress in aptamer-mediated drug delivery vehicles for cancer targeting and its implications in addressing chemotherapeutic challenges. Theranostics. 2014;4(9):931–944.25057317
   PubMed Web of Science ®Google Scholar
• Zhao F, Zhou J, Su X, et al. A smart responsive dual aptamers-targeted bubble-generating nanosystem for cancer triplex therapy and ultrasound imaging. Small. 2017;13(20):16039.
   Web of Science ®Google Scholar
• Li FQ, Mei H, Xie XD, et al. Aptamer-conjugated chitosan-anchored liposomal complexes for targeted delivery of erlotinib to EGFR-mutated lung cancer cells. Aaps J. 2017;19(3):814–826.28233244
   PubMed Web of Science ®Google Scholar
• Ribes A, Aznar E, Bernardos A, et al. Fluorogenic sensing of carcinogenic bisphenol a using aptamer-capped mesoporous silica nanoparticles. Chem a Eur J. 2017;23(36):8581–8584.
   PubMed Web of Science ®Google Scholar
• Wang K, Yao H, Meng Y, Wang Y, Yan X, Huang R. Specific aptamer-conjugated mesoporous silica-carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy. Acta Biomater. 2015;16:196–205.25596325
   PubMed Web of Science ®Google Scholar
• Lee H, Dam DHM, Ha JW, Yue J, Odom TW. Enhanced human epidermal growth factor receptor 2 degradation in breast cancer cells by lysosome-targeting gold nanoconstructs. ACS Nano. 2015;9(10):9859–9867.26335372
   PubMed Web of Science ®Google Scholar
• Shen Y, Zhang J, Hao W, et al. Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells. Int J Nanomedicine. 2018;13:537–553.29416334
   PubMed Web of Science ®Google Scholar
• Yang HL, Lin RW, Rajendran P, et al. Antrodia salmonea-induced oxidative stress abrogates HER-2 signaling cascade and enhanced apoptosis in ovarian carcinoma cells. J Cell Physiol. 2019;234(3):3029–3042.30146791
   PubMed Web of Science ®Google Scholar
• Xue L, Maihle NJ, Yu X, Tang SC, Liu HY. Synergistic Targeting HER2 and EGFR with bivalent aptamer-siRNA chimera efficiently inhibits HER2-positive tumor growth. Mol Pharm. 2018;15(11):4801–4813.30222359
   PubMedGoogle Scholar
• Hou L, Zheng YZ, Wang YC, et al. Self-regulated carboxyphenylboronic acid-modified mesoporous silica nanoparticles with “touch switch” releasing property for insulin delivery. ACS Appl Mater Interfaces. 2018;10(26):21927–21938.29932320
   PubMed Web of Science ®Google Scholar
• Resnier P, Montier T, Mathieu V, Benoit JP, Passirani C. A review of the current status of siRNA nanomedicines in the treatment of cancer. Biomaterials. 2013;34(27):6429–6443.23727262
   PubMed Web of Science ®Google Scholar
• Tarn D, Ferris DP, Barnes JC, Ambrogio MW, Stoddart JF, Zink JI. A reversible light-operated nanovalve on mesoporous silica nanoparticles. Nanoscale. 2014;6(6):3335–3343.24519642
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ang CY, Li M, et al. Polymer-coated hollow mesoporous silica nanoparticles for triple-responsive drug delivery. ACS Appl Mater Interfaces. 2015;7(32):18179–18187.26221866
   PubMed Web of Science ®Google Scholar
• Banizs AB, Huang T, Nakamoto RK, Shi W, He J. Endocytosis pathways of endothelial cell derived exosomes Molecular Pharmaceutics. 2018;15(12):5585–5590.30351959
   PubMedGoogle Scholar
• Orellana-Tavra C, Haddad S, Marshall RJ, et al. Tuning the endocytosis mechanism of Zr-based metal-organic frameworks through linker functionalization. ACS Appl Mater Interfaces. 2017;9(41):35516–35525.28925254
   PubMed Web of Science ®Google Scholar
• Zhang S, Gao H, Bao G. Physical principles of nanoparticle cellular endocytosis. ACS Nano. 2015;9(9):8655–8671.26256227
   PubMed Web of Science ®Google Scholar
• Eissa S, Siaj M, Zourob M. Aptamer-based competitive electrochemical biosensor for brevetoxin-2. Biosens Bioelectron. 2015;69:148–154.25725463
   PubMed Web of Science ®Google Scholar
• Nasrollahi F, Varshosaz J, Khodadadi AA, Lim S, Jahanian-Najafabadi A. Targeted delivery of docetaxel by use of transferrin/poly(allylamine hydrochloride)-functionalized graphene oxide nanocarrier. ACS Appl Mater Interfaces. 2016;8(21):13282–13293.27158834
   PubMed Web of Science ®Google Scholar
• Kuo HP, Chuang TC, Yeh MH, et al. Growth suppression of HER2-overexpressing breast cancer cells by berberine via modulation of the HER2/PI3K/Akt signaling pathway. J Agric Food Chem. 2011;59(15):8216–8224.21699261
   PubMed Web of Science ®Google Scholar